Accessibility Menu
Alphatec logo

Alphatec(NASDAQ) ATEC

Market Cap$1.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-91%
5 Year-34%
1 Year-38%
1 Month+1%
$9.32
+1.19%
+0.11Today
After hours$9.30-$0.02 (-0.22%)
Alphatec last closing stock price
MetricPriceDate
Last closeUSD 9.312026-08-07
Alphatec stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.21%USD 9.522026-07-31
1 month+1.09%USD 9.212026-07-08
3 month+23.8%USD 7.522026-05-08
Year to date-55.75%USD 21.042025-12-31
1 year-37.52%USD 14.902025-08-07
3 year-39.35%USD 15.352023-08-08
5 year-33.55%USD 14.012021-08-06
Since inception-91.36%USD 107.762006-06-02

Alphatec Financials at a Glance

Market Cap

$1.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$815.05M

Net Income (TTM)

-$109.99M

EPS (TTM)

-$0.72

P/E Ratio

-13.00

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$9.32

Volume

2,412,786

Open

$9.34

Previous Close

$9.31

Daily Range

$9.05 - $9.34

52-Week Range

$6.82 - $23.29

Estimated Earnings Date

Oct 29, 2026

About Alphatec

Alphatec makes tools and software for doctors who perform spine surgery. These products help surgeons fix back problems more safely and accurately. The company focuses entirely on improving how patients recover from spine operations.

Tools for the Operating Room

  • SafeOp Monitoring: Electronic system that watches nerves during surgery to help prevent injuries.
  • Sigma Access: Tools that give doctors a better view of the spine while they work.
  • Invictus Fixation: Screws and rods used to stabilize the spine; accounts for 38% of net sales in 2025.
  • EOS Imaging: X-ray machine that makes 3D maps of the body to plan surgeries.
  • Biologics: Materials made from donated tissue that help bones fuse together after an operation.

Strategic Moves and Buying Tech

  • Acquired SafeOp Surgical to add automated nerve monitoring technology to its spine procedures.
  • Purchased EOS imaging to integrate 3D imaging and full-body alignment tools into patient care.
  • Acquired Valence in 2023 to bring robotic navigation and guidance to its surgical workflow.
  • Launched EOS Insight in 2024 to automate surgical planning using 3D models and bone density data.
  • Expanded into Australia, New Zealand, and Japan to establish an international surgical implant business.

What Makes Alphatec Different?

Alphatec maintains a total focus on spine care while many larger competitors work across multiple medical fields. It operates a specialized laboratory in California where surgeons practice new techniques using the company's latest technology.

A Look at the Finances

  • Annual revenue reached $764.2 million in 2025, a 25% increase from the prior year.
  • Quarterly revenue reached $212.9 million in Q4 2025, up 20.4% year-over-year.
  • Operating losses narrowed to $5.4 million in Q4 2025, an improvement from $23.8 million.
  • Free cash flow turned positive at $9.6 million in Q4 2025, up 41.2% year-over-year.

Bottom Line

Alphatec has transitioned from a general device maker to a specialized spine technology provider. Its combination of surgical hardware and digital planning software has driven consistent growth in surgical volume.

AI Generated • Apr 30, 2026

Industry

Healthcare Equipment and Supplies

Employees

913

CEO

Patrick S. Miles

Headquarters

Carlsbad, CA 92008, US

ATEC Financials

Key Financial Metrics (TTM)

Gross Margin

66.15%

Operating Margin

-5.55%

Net Income Margin

-13.50%

Return on Equity

-818.99%

Return on Capital

-12.52%

Return on Assets

-13.91%

Earnings Yield

-7.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

154.45M

Volume

2.41M

Avg. Volume

2.93M

Financials (TTM)

Gross Profit

$539.13M

Operating Income

-$45.26M

EBITDA

$13.46M

Operating Cash Flow

$57.82M

Capital Expenditure

-$64.46M

Free Cash Flow

-$6.64M

Cash & ST Invst.

$118.66M

Total Debt

$604.02M

Alphatec Performance Analysis

Alphatec annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 350,867,00044.3%
20232023-12-31USD 482,262,00037.4%
20242024-12-31USD 611,562,00026.8%
20252025-12-31USD 764,155,00025.0%
Alphatec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-305.9%
Q42025-12-318.4%
Q12026-03-31-9.8%
Q22026-06-3011.1%
Alphatec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.46-2.4%
20232023-12-31USD -1.545.2%
20242024-12-31USD -1.13-26.3%
20252025-12-31USD -0.96-15.8%
Alphatec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3029.6%
Q42025-12-3121.1%
Q12026-03-31-46.7%
Q22026-06-3027.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$213.51M

+15.1%

Gross Profit

$154.10M

+19.4%

Gross Margin

72.17%

N/A

Market Cap

$1.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.57M

N/A

Employees

913

N/A

Net Income

-$25.78M

+37.3%

EBITDA

$6.46M

+177.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$118.66M

-24.4%

Total Debt

$604.02M

+3.0%

Accounts Receivable

$110.13M

+10.3%

Inventory

$194.89M

+14.8%

Long Term Debt

$532.41M

-7.9%

Short Term Debt

$71.61M

+749.1%

Return on Assets

-13.91%

N/A

Return on Invested Capital

-8.18%

N/A

Free Cash Flow

-$10.22M

-402.8%

Operating Cash Flow

$21.80M

+40.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SGRYSurgery Partners, Inc.
$15.53+4.09%
HTFLHeartflow, Inc. Common Stock
$28.82+5.99%
ZLABZai Lab Limited
$23.32+11.69%
IRONDisc Medicine, Inc.
$77.44+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About ATEC

What is the current price of Alphatec?

Alphatec is trading at $9.31 per share.

What is the 52-week range for Alphatec?

Over the past 52 weeks, Alphatec has traded between $6.82 and $23.29.

How much debt does Alphatec have?

As of the most recent reporting period, Alphatec reported total debt of $604.02M.

How much cash does Alphatec have on hand?

Alphatec reported $118.66M in cash and cash equivalents in its most recent financial results.

What is Alphatec’s dividend yield?

Alphatec does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.